 David Bentley
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 54 | 2022 | 284 | 10.230 |
Why?
| | Transcription, Genetic | 55 | 2023 | 1313 | 6.880 |
Why?
| | RNA Precursors | 16 | 2023 | 136 | 4.570 |
Why?
| | RNA, Messenger | 33 | 2021 | 2552 | 4.090 |
Why?
| | RNA Processing, Post-Transcriptional | 15 | 2021 | 82 | 3.680 |
Why?
| | RNA Splicing | 16 | 2023 | 245 | 2.720 |
Why?
| | Transcription Elongation, Genetic | 6 | 2018 | 20 | 2.460 |
Why?
| | Saccharomyces cerevisiae Proteins | 12 | 2017 | 333 | 2.460 |
Why?
| | Histones | 9 | 2018 | 535 | 1.990 |
Why?
| | Poly A | 9 | 2022 | 46 | 1.880 |
Why?
| | Transcription Termination, Genetic | 3 | 2019 | 12 | 1.820 |
Why?
| | Saccharomyces cerevisiae | 11 | 2022 | 476 | 1.800 |
Why?
| | Transcriptional Elongation Factors | 6 | 2022 | 32 | 1.780 |
Why?
| | Nuclear Proteins | 11 | 2019 | 591 | 1.680 |
Why?
| | Exoribonucleases | 4 | 2019 | 40 | 1.600 |
Why?
| | RNA-Binding Proteins | 10 | 2021 | 344 | 1.570 |
Why?
| | Alternative Splicing | 8 | 2021 | 187 | 1.470 |
Why?
| | Cyclin-Dependent Kinases | 8 | 2020 | 111 | 1.240 |
Why?
| | Promoter Regions, Genetic | 14 | 2018 | 1131 | 1.140 |
Why?
| | RNA 3' End Processing | 5 | 2018 | 11 | 1.130 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 6 | 2018 | 26 | 1.040 |
Why?
| | Chromatin | 8 | 2017 | 428 | 1.020 |
Why?
| | RNA | 7 | 2021 | 809 | 0.990 |
Why?
| | HEK293 Cells | 8 | 2021 | 591 | 0.980 |
Why?
| | Protein Processing, Post-Translational | 4 | 2019 | 399 | 0.980 |
Why?
| | Transcriptional Activation | 5 | 2018 | 337 | 0.980 |
Why?
| | Polyadenylation | 3 | 2022 | 37 | 0.880 |
Why?
| | RNA Caps | 7 | 2014 | 31 | 0.830 |
Why?
| | DNA-Binding Proteins | 9 | 2019 | 1314 | 0.790 |
Why?
| | Transcription Factor TFIIH | 6 | 2020 | 34 | 0.750 |
Why?
| | Transcription Initiation, Genetic | 2 | 2018 | 11 | 0.730 |
Why?
| | Phosphorylation | 13 | 2022 | 1569 | 0.690 |
Why?
| | Protein Phosphatase 1 | 1 | 2019 | 28 | 0.680 |
Why?
| | Transcription Factors | 12 | 2012 | 1528 | 0.660 |
Why?
| | Introns | 5 | 2023 | 227 | 0.650 |
Why?
| | DNA, Fungal | 2 | 2017 | 69 | 0.650 |
Why?
| | Chromatin Assembly and Disassembly | 3 | 2017 | 88 | 0.650 |
Why?
| | RNA Cleavage | 1 | 2018 | 7 | 0.640 |
Why?
| | Cell Line | 16 | 2021 | 2635 | 0.620 |
Why?
| | Models, Genetic | 7 | 2015 | 562 | 0.590 |
Why?
| | Nucleosomes | 2 | 2011 | 123 | 0.560 |
Why?
| | RNA, Catalytic | 2 | 2009 | 182 | 0.550 |
Why?
| | Cell Nucleus | 6 | 2022 | 554 | 0.550 |
Why?
| | Mutation | 17 | 2018 | 3344 | 0.540 |
Why?
| | Kinetics | 6 | 2019 | 1551 | 0.540 |
Why?
| | Yeasts | 4 | 2011 | 49 | 0.530 |
Why?
| | Methyltransferases | 3 | 2004 | 61 | 0.530 |
Why?
| | Recombinant Fusion Proteins | 4 | 2016 | 616 | 0.510 |
Why?
| | Exons | 11 | 2021 | 302 | 0.490 |
Why?
| | Transcription Factors, TFII | 5 | 2012 | 37 | 0.490 |
Why?
| | Protein Engineering | 1 | 2016 | 98 | 0.490 |
Why?
| | DNA Polymerase II | 3 | 2005 | 37 | 0.470 |
Why?
| | Binding Sites | 11 | 2019 | 1168 | 0.470 |
Why?
| | RNA, Fungal | 2 | 2011 | 66 | 0.470 |
Why?
| | Terminator Regions, Genetic | 5 | 2006 | 12 | 0.460 |
Why?
| | Exonucleases | 2 | 2022 | 8 | 0.450 |
Why?
| | HeLa Cells | 10 | 2015 | 562 | 0.450 |
Why?
| | Polymerase Chain Reaction | 3 | 2016 | 993 | 0.440 |
Why?
| | Genes, myc | 5 | 2007 | 46 | 0.440 |
Why?
| | RNA Stability | 2 | 2012 | 90 | 0.430 |
Why?
| | Oocytes | 10 | 2005 | 170 | 0.430 |
Why?
| | Nucleotidyltransferases | 4 | 2004 | 26 | 0.420 |
Why?
| | Protein Kinases | 3 | 2010 | 307 | 0.410 |
Why?
| | Genes, Fungal | 2 | 2010 | 49 | 0.410 |
Why?
| | Humans | 65 | 2022 | 114623 | 0.380 |
Why?
| | Phosphoprotein Phosphatases | 2 | 2009 | 64 | 0.370 |
Why?
| | Protein Structure, Tertiary | 9 | 2015 | 796 | 0.370 |
Why?
| | Fungal Proteins | 5 | 2011 | 119 | 0.370 |
Why?
| | Phosphoserine | 1 | 2010 | 33 | 0.360 |
Why?
| | Neoplasm Proteins | 3 | 2007 | 384 | 0.350 |
Why?
| | Histone-Lysine N-Methyltransferase | 3 | 2017 | 96 | 0.350 |
Why?
| | Gene Expression Regulation, Fungal | 3 | 2017 | 59 | 0.350 |
Why?
| | Dichlororibofuranosylbenzimidazole | 6 | 2009 | 8 | 0.340 |
Why?
| | RNA Folding | 2 | 2021 | 33 | 0.320 |
Why?
| | Animals | 34 | 2018 | 31694 | 0.310 |
Why?
| | Genes, Regulator | 3 | 2004 | 34 | 0.310 |
Why?
| | RNA Splice Sites | 3 | 2021 | 33 | 0.300 |
Why?
| | Molecular Sequence Data | 14 | 2014 | 2785 | 0.290 |
Why?
| | Protein Binding | 6 | 2019 | 1889 | 0.290 |
Why?
| | Repressor Proteins | 3 | 2014 | 366 | 0.280 |
Why?
| | Spliceosomes | 2 | 2023 | 38 | 0.270 |
Why?
| | Macromolecular Substances | 5 | 2010 | 200 | 0.260 |
Why?
| | Peptide Elongation Factors | 2 | 2022 | 13 | 0.250 |
Why?
| | Lysine | 1 | 2007 | 242 | 0.240 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2004 | 4 | 0.230 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 1997 | 51 | 0.230 |
Why?
| | RNA Polymerase III | 2 | 2017 | 25 | 0.230 |
Why?
| | RNA Editing | 3 | 2009 | 20 | 0.220 |
Why?
| | Ovarian Neoplasms | 4 | 2013 | 388 | 0.220 |
Why?
| | Methylation | 3 | 2011 | 208 | 0.220 |
Why?
| | Models, Biological | 5 | 2020 | 1620 | 0.210 |
Why?
| | Amino Acid Sequence | 9 | 2014 | 1982 | 0.210 |
Why?
| | RNA, Antisense | 1 | 2022 | 17 | 0.210 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2012 | 128 | 0.210 |
Why?
| | Models, Theoretical | 1 | 2006 | 515 | 0.200 |
Why?
| | Nucleotides | 1 | 2022 | 112 | 0.200 |
Why?
| | Mice | 13 | 2018 | 14860 | 0.200 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2017 | 1141 | 0.200 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2003 | 100 | 0.190 |
Why?
| | Ultraviolet Rays | 2 | 2018 | 363 | 0.190 |
Why?
| | Gene Products, tat | 2 | 1998 | 19 | 0.190 |
Why?
| | Gene Expression Regulation | 7 | 2018 | 2319 | 0.180 |
Why?
| | HCT116 Cells | 2 | 2018 | 70 | 0.180 |
Why?
| | Proto-Oncogenes | 3 | 1989 | 26 | 0.180 |
Why?
| | Base Sequence | 12 | 2007 | 2114 | 0.180 |
Why?
| | Transfection | 7 | 2007 | 866 | 0.180 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2014 | 59 | 0.170 |
Why?
| | HIV-2 | 2 | 1997 | 15 | 0.170 |
Why?
| | Genome, Human | 3 | 2015 | 347 | 0.170 |
Why?
| | Xenopus | 6 | 2003 | 97 | 0.170 |
Why?
| | Adenosine Triphosphatases | 2 | 2012 | 153 | 0.170 |
Why?
| | Peptide Chain Elongation, Translational | 2 | 1998 | 18 | 0.160 |
Why?
| | 3' Flanking Region | 1 | 2018 | 7 | 0.160 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 2 | 2009 | 14 | 0.160 |
Why?
| | Hydrolysis | 2 | 2011 | 173 | 0.160 |
Why?
| | Phenanthrenes | 1 | 2018 | 10 | 0.160 |
Why?
| | Metallothionein | 1 | 1998 | 24 | 0.160 |
Why?
| | Diterpenes | 1 | 2018 | 31 | 0.160 |
Why?
| | Coenzymes | 1 | 1998 | 16 | 0.160 |
Why?
| | Epoxy Compounds | 1 | 2018 | 31 | 0.160 |
Why?
| | Isotonic Solutions | 1 | 2018 | 39 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2001 | 246 | 0.150 |
Why?
| | Saline Solution, Hypertonic | 1 | 2018 | 53 | 0.150 |
Why?
| | Genes | 5 | 2004 | 223 | 0.150 |
Why?
| | Enzyme Inhibitors | 2 | 2003 | 750 | 0.140 |
Why?
| | Trans-Activators | 2 | 2002 | 367 | 0.140 |
Why?
| | Progestins | 1 | 2017 | 75 | 0.140 |
Why?
| | Cell Cycle Proteins | 2 | 2003 | 551 | 0.140 |
Why?
| | Xenopus laevis | 4 | 2004 | 118 | 0.130 |
Why?
| | Neoplasms | 3 | 2021 | 2097 | 0.130 |
Why?
| | Plasmids | 5 | 2006 | 343 | 0.130 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2016 | 14 | 0.130 |
Why?
| | Drosophila Proteins | 2 | 2003 | 164 | 0.130 |
Why?
| | Protein Domains | 1 | 2017 | 207 | 0.130 |
Why?
| | HIV-1 | 2 | 1998 | 768 | 0.130 |
Why?
| | Receptors, Progesterone | 1 | 2017 | 319 | 0.120 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 78 | 0.120 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2007 | 270 | 0.120 |
Why?
| | Proto-Oncogene Proteins | 3 | 1988 | 608 | 0.120 |
Why?
| | Receptors, Estrogen | 1 | 2017 | 372 | 0.120 |
Why?
| | Escherichia coli Proteins | 1 | 2016 | 162 | 0.120 |
Why?
| | Immunoglobulin M | 1 | 2015 | 246 | 0.120 |
Why?
| | Breast Neoplasms | 4 | 2017 | 1862 | 0.120 |
Why?
| | Signal Transduction | 4 | 2019 | 4509 | 0.110 |
Why?
| | Lymphocytes | 1 | 2015 | 330 | 0.110 |
Why?
| | Granulomatous Disease, Chronic | 2 | 1991 | 60 | 0.110 |
Why?
| | Histone Chaperones | 1 | 2013 | 13 | 0.110 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2013 | 34 | 0.110 |
Why?
| | Cyclin-Dependent Kinase 9 | 2 | 2012 | 9 | 0.110 |
Why?
| | Antibodies | 4 | 2006 | 371 | 0.110 |
Why?
| | Cell Line, Tumor | 5 | 2014 | 2710 | 0.110 |
Why?
| | Cytidine Deaminase | 1 | 2013 | 58 | 0.110 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 2013 | 44 | 0.110 |
Why?
| | Chloramphenicol O-Acetyltransferase | 3 | 1997 | 38 | 0.110 |
Why?
| | DNA, Neoplasm | 1 | 2013 | 157 | 0.100 |
Why?
| | Escherichia coli | 1 | 2016 | 720 | 0.100 |
Why?
| | Carcinogenesis | 1 | 2013 | 177 | 0.100 |
Why?
| | Ovary | 1 | 2013 | 191 | 0.100 |
Why?
| | Globins | 3 | 1997 | 21 | 0.100 |
Why?
| | Sequence Deletion | 2 | 2003 | 167 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-myc | 3 | 2009 | 115 | 0.100 |
Why?
| | beta-Globins | 1 | 2011 | 10 | 0.100 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2011 | 23 | 0.100 |
Why?
| | Protein Interaction Mapping | 1 | 2012 | 101 | 0.100 |
Why?
| | 3' Untranslated Regions | 2 | 2022 | 129 | 0.100 |
Why?
| | Serine | 2 | 2009 | 126 | 0.090 |
Why?
| | Plasma | 1 | 2013 | 211 | 0.090 |
Why?
| | Repetitive Sequences, Amino Acid | 2 | 2001 | 16 | 0.090 |
Why?
| | Recombinant Proteins | 4 | 1998 | 1230 | 0.090 |
Why?
| | DNA Helicases | 3 | 1997 | 133 | 0.090 |
Why?
| | Time Factors | 4 | 2017 | 6112 | 0.090 |
Why?
| | Isoquinolines | 2 | 2004 | 36 | 0.090 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 1990 | 18 | 0.090 |
Why?
| | DNA | 5 | 2005 | 1352 | 0.090 |
Why?
| | Genes, Reporter | 2 | 2003 | 257 | 0.090 |
Why?
| | RNA, Untranslated | 1 | 2011 | 113 | 0.090 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2010 | 81 | 0.090 |
Why?
| | Chromosome Deletion | 4 | 1992 | 95 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2015 | 950 | 0.090 |
Why?
| | Hepatitis Delta Virus | 1 | 2009 | 6 | 0.080 |
Why?
| | Fluorouracil | 1 | 2010 | 152 | 0.080 |
Why?
| | Deoxycytidine | 1 | 2010 | 138 | 0.080 |
Why?
| | Adenosine Deaminase | 2 | 2007 | 24 | 0.080 |
Why?
| | Cricetulus | 1 | 2009 | 97 | 0.080 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2017 | 22 | 0.080 |
Why?
| | CHO Cells | 1 | 2009 | 138 | 0.080 |
Why?
| | Fibronectins | 3 | 2009 | 108 | 0.080 |
Why?
| | Cricetinae | 1 | 2009 | 253 | 0.080 |
Why?
| | rho GTP-Binding Proteins | 1 | 2009 | 61 | 0.080 |
Why?
| | RNA Transport | 1 | 2008 | 23 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 636 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2008 | 110 | 0.080 |
Why?
| | Phosphoproteins | 1 | 1990 | 298 | 0.080 |
Why?
| | Ribonucleoproteins | 1 | 2008 | 85 | 0.080 |
Why?
| | Amanitins | 2 | 2004 | 4 | 0.070 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 2 | 1998 | 20 | 0.070 |
Why?
| | Bacteroides | 1 | 2007 | 16 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2020 | 785 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2007 | 95 | 0.070 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2007 | 51 | 0.070 |
Why?
| | Fragile X Syndrome | 1 | 2007 | 64 | 0.070 |
Why?
| | Cell Nucleus Structures | 1 | 2006 | 3 | 0.070 |
Why?
| | Receptors, AMPA | 1 | 2007 | 119 | 0.070 |
Why?
| | Heterozygote | 1 | 2007 | 251 | 0.070 |
Why?
| | Oncogenes | 1 | 1986 | 103 | 0.070 |
Why?
| | Allosteric Regulation | 1 | 2006 | 81 | 0.070 |
Why?
| | Substrate Specificity | 2 | 1997 | 352 | 0.060 |
Why?
| | Uracil | 1 | 2005 | 28 | 0.060 |
Why?
| | DNA Repair | 2 | 1997 | 184 | 0.060 |
Why?
| | Glycoproteins | 1 | 2007 | 304 | 0.060 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2004 | 17 | 0.060 |
Why?
| | Physical Chromosome Mapping | 1 | 2004 | 16 | 0.060 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2004 | 18 | 0.060 |
Why?
| | Genetic Testing | 1 | 2007 | 379 | 0.060 |
Why?
| | Sequence Analysis, DNA | 3 | 2004 | 723 | 0.060 |
Why?
| | Genome-Wide Association Study | 1 | 2010 | 1177 | 0.060 |
Why?
| | Genes, cdc | 1 | 2004 | 10 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 2 | 1996 | 138 | 0.060 |
Why?
| | Antineoplastic Agents | 2 | 2013 | 1879 | 0.060 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 615 | 0.060 |
Why?
| | Intestines | 1 | 2007 | 326 | 0.060 |
Why?
| | BRCA2 Protein | 1 | 2003 | 41 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2007 | 529 | 0.050 |
Why?
| | RNA, Small Nuclear | 1 | 2003 | 31 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 197 | 0.050 |
Why?
| | Female | 13 | 2017 | 59466 | 0.050 |
Why?
| | Simian virus 40 | 1 | 2002 | 22 | 0.050 |
Why?
| | Tumor Cells, Cultured | 2 | 2017 | 849 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1355 | 0.050 |
Why?
| | Binding Sites, Antibody | 1 | 1982 | 36 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 502 | 0.050 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2002 | 31 | 0.050 |
Why?
| | Genomics | 3 | 2013 | 635 | 0.050 |
Why?
| | Operon | 1 | 1982 | 59 | 0.050 |
Why?
| | Carcinoma | 1 | 2003 | 198 | 0.050 |
Why?
| | Immunoglobulin Variable Region | 1 | 1982 | 72 | 0.050 |
Why?
| | Ribonucleases | 2 | 2003 | 52 | 0.050 |
Why?
| | Human Genome Project | 1 | 2001 | 14 | 0.050 |
Why?
| | Templates, Genetic | 2 | 1996 | 59 | 0.050 |
Why?
| | HL-60 Cells | 1 | 2020 | 28 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2007 | 3881 | 0.040 |
Why?
| | Fatigue | 1 | 2002 | 294 | 0.040 |
Why?
| | DNA, Plant | 1 | 1999 | 11 | 0.040 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 1999 | 27 | 0.040 |
Why?
| | Genes, Plant | 1 | 1999 | 43 | 0.040 |
Why?
| | Minichromosome Maintenance Complex Component 2 | 1 | 1999 | 4 | 0.040 |
Why?
| | Holoenzymes | 1 | 1999 | 21 | 0.040 |
Why?
| | RNA Helicases | 1 | 1999 | 20 | 0.040 |
Why?
| | Chromatography, Affinity | 1 | 1999 | 80 | 0.040 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2002 | 219 | 0.040 |
Why?
| | Mammals | 2 | 1998 | 244 | 0.040 |
Why?
| | Cell Differentiation | 1 | 1986 | 1700 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1518 | 0.040 |
Why?
| | Evolution, Molecular | 3 | 2013 | 430 | 0.040 |
Why?
| | Arabidopsis | 1 | 1999 | 79 | 0.040 |
Why?
| | Carrier Proteins | 2 | 2003 | 695 | 0.040 |
Why?
| | Proteins | 3 | 2004 | 908 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 2 | 2002 | 151 | 0.040 |
Why?
| | Dogs | 1 | 1999 | 334 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2002 | 350 | 0.040 |
Why?
| | Peptide Initiation Factors | 1 | 1997 | 17 | 0.040 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 1997 | 27 | 0.040 |
Why?
| | Peptide Fragments | 3 | 1998 | 665 | 0.040 |
Why?
| | Tretinoin | 2 | 1990 | 122 | 0.040 |
Why?
| | Mediator Complex | 1 | 1998 | 52 | 0.040 |
Why?
| | Glutathione Transferase | 1 | 1997 | 93 | 0.040 |
Why?
| | Alleles | 2 | 2013 | 789 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 2 | 1992 | 187 | 0.040 |
Why?
| | Burkitt Lymphoma | 2 | 1988 | 52 | 0.040 |
Why?
| | Cell Survival | 1 | 2020 | 1020 | 0.040 |
Why?
| | Spodoptera | 1 | 1997 | 36 | 0.040 |
Why?
| | Drosophila | 1 | 1998 | 133 | 0.040 |
Why?
| | Xeroderma Pigmentosum Group D Protein | 1 | 1996 | 4 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2001 | 104 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 314 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 275 | 0.030 |
Why?
| | Sp1 Transcription Factor | 1 | 1996 | 23 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 1996 | 61 | 0.030 |
Why?
| | Herpes Simplex Virus Protein Vmw65 | 1 | 1995 | 5 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1990 | 522 | 0.030 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1995 | 27 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 555 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 733 | 0.030 |
Why?
| | Simplexvirus | 1 | 1995 | 80 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 698 | 0.030 |
Why?
| | Apoptosis | 2 | 2017 | 2362 | 0.030 |
Why?
| | Estrogens | 1 | 2017 | 312 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 1994 | 54 | 0.030 |
Why?
| | TATA Box | 1 | 1994 | 22 | 0.030 |
Why?
| | Blotting, Western | 1 | 1997 | 1147 | 0.030 |
Why?
| | Histone Deacetylase 1 | 1 | 2014 | 16 | 0.030 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 24 | 0.030 |
Why?
| | Granulosa Cell Tumor | 1 | 2013 | 6 | 0.030 |
Why?
| | Time-Lapse Imaging | 1 | 2013 | 19 | 0.030 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2013 | 41 | 0.030 |
Why?
| | Mediator Complex Subunit 1 | 1 | 2013 | 4 | 0.030 |
Why?
| | Piperazines | 1 | 1995 | 309 | 0.030 |
Why?
| | Retinoblastoma Protein | 1 | 2013 | 52 | 0.030 |
Why?
| | Hyperplasia | 1 | 2013 | 163 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2013 | 88 | 0.030 |
Why?
| | Molecular Weight | 2 | 1990 | 331 | 0.030 |
Why?
| | HIV | 1 | 1994 | 208 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 76 | 0.030 |
Why?
| | Genetics, Medical | 2 | 2004 | 24 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 299 | 0.030 |
Why?
| | Tomography, Optical Coherence | 1 | 2013 | 130 | 0.030 |
Why?
| | Gene Duplication | 2 | 2004 | 62 | 0.030 |
Why?
| | Ubiquitination | 1 | 2012 | 86 | 0.030 |
Why?
| | CpG Islands | 2 | 2004 | 117 | 0.030 |
Why?
| | Immunoblotting | 1 | 2012 | 283 | 0.020 |
Why?
| | Exome | 1 | 2013 | 200 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 372 | 0.020 |
Why?
| | Plant Proteins | 2 | 2003 | 81 | 0.020 |
Why?
| | Cytochrome b Group | 1 | 1991 | 16 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 351 | 0.020 |
Why?
| | Dinucleoside Phosphates | 1 | 1991 | 24 | 0.020 |
Why?
| | X Chromosome | 1 | 1991 | 47 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1040 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 329 | 0.020 |
Why?
| | Genes, Recessive | 1 | 1991 | 73 | 0.020 |
Why?
| | Organoplatinum Compounds | 1 | 2010 | 37 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 1990 | 73 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 807 | 0.020 |
Why?
| | Capecitabine | 1 | 2010 | 45 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 961 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 1990 | 120 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2186 | 0.020 |
Why?
| | Point Mutation | 2 | 2003 | 216 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 1995 | 785 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2013 | 554 | 0.020 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2009 | 18 | 0.020 |
Why?
| | Kidney | 1 | 1996 | 1188 | 0.020 |
Why?
| | Binding, Competitive | 1 | 1989 | 193 | 0.020 |
Why?
| | DNA Restriction Enzymes | 1 | 1988 | 54 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 522 | 0.020 |
Why?
| | Protein Biosynthesis | 2 | 1988 | 385 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 1988 | 38 | 0.020 |
Why?
| | Translocation, Genetic | 1 | 1987 | 94 | 0.020 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2007 | 24 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 740 | 0.020 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2007 | 34 | 0.020 |
Why?
| | DNA Damage | 1 | 2009 | 351 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 1986 | 21 | 0.020 |
Why?
| | Symbiosis | 1 | 2007 | 64 | 0.020 |
Why?
| | Antibodies, Phospho-Specific | 1 | 2006 | 1 | 0.020 |
Why?
| | Lung Neoplasms | 2 | 2013 | 2177 | 0.020 |
Why?
| | Adult | 3 | 2017 | 30528 | 0.020 |
Why?
| | Gene Deletion | 1 | 2007 | 356 | 0.020 |
Why?
| | Lymphoma | 1 | 1986 | 177 | 0.020 |
Why?
| | Neutrophils | 1 | 1990 | 1176 | 0.020 |
Why?
| | Contig Mapping | 1 | 2004 | 10 | 0.010 |
Why?
| | Pseudogenes | 1 | 2004 | 18 | 0.010 |
Why?
| | Base Composition | 1 | 2004 | 75 | 0.010 |
Why?
| | Pan troglodytes | 1 | 2004 | 47 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2007 | 493 | 0.010 |
Why?
| | Co-Repressor Proteins | 1 | 2003 | 13 | 0.010 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2003 | 58 | 0.010 |
Why?
| | Adenovirus E1A Proteins | 1 | 2003 | 11 | 0.010 |
Why?
| | Gene Amplification | 1 | 2003 | 95 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 256 | 0.010 |
Why?
| | Gene Silencing | 1 | 2003 | 171 | 0.010 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 2002 | 14 | 0.010 |
Why?
| | Replication Origin | 1 | 2002 | 15 | 0.010 |
Why?
| | Adenoviridae | 1 | 2003 | 184 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 2006 | 669 | 0.010 |
Why?
| | COS Cells | 1 | 2002 | 175 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 2002 | 43 | 0.010 |
Why?
| | HT29 Cells | 1 | 2002 | 35 | 0.010 |
Why?
| | Ecosystem | 1 | 2007 | 502 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 338 | 0.010 |
Why?
| | Immunoglobulin Light Chains | 1 | 1982 | 35 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2002 | 80 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 2003 | 191 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 1986 | 766 | 0.010 |
Why?
| | Bacteriophage lambda | 1 | 1982 | 81 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2007 | 736 | 0.010 |
Why?
| | GC Rich Sequence | 1 | 2001 | 4 | 0.010 |
Why?
| | Public Sector | 1 | 2001 | 17 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 923 | 0.010 |
Why?
| | Private Sector | 1 | 2001 | 51 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2002 | 304 | 0.010 |
Why?
| | Genetic Diseases, Inborn | 1 | 2001 | 36 | 0.010 |
Why?
| | Physical Fitness | 1 | 2002 | 179 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2001 | 101 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2001 | 218 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 2002 | 522 | 0.010 |
Why?
| | Disability Evaluation | 1 | 2002 | 271 | 0.010 |
Why?
| | Phylogeny | 1 | 2003 | 789 | 0.010 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 1986 | 534 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 487 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2003 | 463 | 0.010 |
Why?
| | Drug Industry | 1 | 2001 | 103 | 0.010 |
Why?
| | Heterochromatin | 1 | 1999 | 32 | 0.010 |
Why?
| | Species Specificity | 1 | 2001 | 542 | 0.010 |
Why?
| | Quality of Life | 1 | 2010 | 2353 | 0.010 |
Why?
| | Chromosomes | 1 | 1999 | 85 | 0.010 |
Why?
| | Regression Analysis | 1 | 2002 | 944 | 0.010 |
Why?
| | Forecasting | 1 | 2001 | 330 | 0.010 |
Why?
| | Genetic Variation | 1 | 2004 | 870 | 0.010 |
Why?
| | Exercise Test | 1 | 2002 | 544 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2002 | 588 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1842 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 353 | 0.010 |
Why?
| | Multigene Family | 1 | 1999 | 190 | 0.010 |
Why?
| | Cloning, Organism | 1 | 1998 | 6 | 0.010 |
Why?
| | Protein Sorting Signals | 1 | 1998 | 16 | 0.010 |
Why?
| | Heart Rate | 1 | 2002 | 709 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 1998 | 62 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 51 | 0.010 |
Why?
| | Guanosine Triphosphate | 1 | 1998 | 85 | 0.010 |
Why?
| | Fetus | 1 | 1982 | 699 | 0.010 |
Why?
| | Rats | 1 | 2006 | 4958 | 0.010 |
Why?
| | Proteome | 1 | 2001 | 339 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1998 | 345 | 0.010 |
Why?
| | Protein Conformation | 1 | 1999 | 805 | 0.010 |
Why?
| | Databases, Factual | 1 | 2001 | 1124 | 0.010 |
Why?
| | Prognosis | 1 | 2003 | 3328 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2003 | 2084 | 0.010 |
Why?
| | Liver | 1 | 1982 | 1634 | 0.010 |
Why?
| | Aged | 1 | 2010 | 19061 | 0.010 |
Why?
| | Exercise | 1 | 2002 | 1644 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1991 | 77 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 6217 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 26719 | 0.010 |
Why?
| | Pregnancy | 1 | 1982 | 5517 | 0.010 |
Why?
| | Reference Values | 1 | 1991 | 742 | 0.010 |
Why?
| | DNA, Recombinant | 1 | 1988 | 41 | 0.000 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 1987 | 16 | 0.000 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 1987 | 27 | 0.000 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 1987 | 33 | 0.000 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 1987 | 38 | 0.000 |
Why?
| | Codon | 1 | 1988 | 86 | 0.000 |
Why?
| | Chickens | 1 | 1988 | 177 | 0.000 |
Why?
| | Male | 1 | 2010 | 55554 | 0.000 |
Why?
| | Biological Evolution | 1 | 1988 | 416 | 0.000 |
Why?
|
|
Bentley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|